Lactiga
3 known investors
Find your way into Lactiga
Sign up to see every warm intro you have to Lactiga
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lactiga team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lactiga is a biotechnology company developing mucosal antibody therapies based on secretory IgA antibodies derived from human breastmilk. Its platform targets conditions such as chronic respiratory disorders, gut inflammation, and immune deficiencies through mucosal immunotherapy.
Founders & leadership
Investors · 3
Checkmate Capital Group LLClisted by Checkmate Capital Group LLCPasadena
How we know: lactiga.com · funding news · Not right? Tell us
Jude Gomilalisted by Jude GomilaLynnwood
How we know: Jude Gomila's portfolio page · Not right? Tell us
1517reportedTelluride · $50K – $1M
How we know: a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeedNov 2020Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Lactiga do?
- Lactiga is a biotechnology company developing mucosal antibody therapies based on secretory IgA antibodies derived from human breastmilk. Its platform targets conditions such as chronic respiratory disorders, gut inflammation, and immune deficiencies through mucosal immunotherapy.
- Who founded Lactiga?
- Lactiga was founded by Rikin Mehta, Rikin Mehta, PharmD/JD, Viraj Mane, PhD.
- Who are Lactiga's investors?
- Lactiga's investors include Checkmate Capital Group LLC, Jude Gomila, 1517.



